| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.535 | 0.004 | 0.535 | Integrin antagonist | 0.387 0.004 DBMET01830 0.422 0.004 DBMET01831 0.387 0.004 DBMET01321 0.422 0.004 DBMET01323 0.358 0.005 DBMET01324 0.294 0.005 DBMET01322 | ||
| 0.532 | 0.004 | 0.532 | Cell adhesion inhibitor | 0.471 0.004 DBMET01830 0.484 0.004 DBMET01831 0.471 0.004 DBMET01321 0.484 0.004 DBMET01323 0.486 0.004 DBMET01324 0.493 0.004 DBMET01325 0.437 0.005 DBMET01322 | ||
| 0.541 | 0.024 | 0.756 | Antithrombotic | 0.509 0.028 DBMET01830 0.572 0.019 DBMET01831 0.509 0.028 DBMET01321 0.572 0.019 DBMET01323 0.399 0.049 DBMET01324 0.756 0.005 DBMET01325 0.548 0.023 DBMET01322 | DBMET01325 | |
| 0.459 | 0.005 | 0.459 | Insulin secretagoues | 0.445 0.005 DBMET01830 0.181 0.047 DBMET01831 0.445 0.005 DBMET01321 0.181 0.047 DBMET01323 0.247 0.02 DBMET01324 0.448 0.005 DBMET01325 0.166 0.059 DBMET01322 | ||
| 0.463 | 0.018 | 0.463 | Platelet antagonist | 0.389 0.029 DBMET01830 0.309 0.05 DBMET01831 0.389 0.029 DBMET01321 0.309 0.05 DBMET01323 0.364 0.035 DBMET01324 0.429 0.022 DBMET01325 0.356 0.037 DBMET01322 | ||
| 0.449 | 0.004 | 0.449 | Cell adhesion molecule inhibitor | 0.357 0.005 DBMET01830 0.338 0.005 DBMET01831 0.357 0.005 DBMET01321 0.338 0.005 DBMET01323 0.316 0.005 DBMET01324 0.382 0.005 DBMET01325 0.262 0.006 DBMET01322 | ||
| 0.443 | 0.017 | 0.71 | Psychostimulant | 0.303 0.042 DBMET01830 0.552 0.008 DBMET01831 0.303 0.042 DBMET01321 0.552 0.008 DBMET01323 0.71 0.004 DBMET01324 0.282 0.048 DBMET01325 0.402 0.022 DBMET01322 | DBMET01324 | |
| 0.474 | 0.058 | 0.699 | Cyclophilin D inhibitor | 0.525 0.043 DBMET01830 0.487 0.054 DBMET01831 0.525 0.043 DBMET01321 0.487 0.054 DBMET01323 0.304 0.159 DBMET01324 0.699 0.014 DBMET01325 0.586 0.03 DBMET01322 | DBMET01325 | |
| 0.417 | 0.006 | 0.424 | Tyrosine 3 hydroxylase inhibitor | 0.356 0.015 DBMET01830 0.424 0.006 DBMET01831 0.356 0.015 DBMET01321 0.424 0.006 DBMET01323 0.365 0.013 DBMET01324 0.361 0.014 DBMET01322 | DBMET01323 | |
| 0.442 | 0.042 | 0.611 | Cholesterol antagonist | 0.434 0.043 DBMET01830 0.48 0.036 DBMET01831 0.434 0.043 DBMET01321 0.48 0.036 DBMET01323 0.306 0.087 DBMET01324 0.611 0.017 DBMET01325 0.473 0.037 DBMET01322 | DBMET01325 | |
| 0.4 | 0.027 | 0.487 | Interleukin 2 agonist | 0.39 0.03 DBMET01830 0.355 0.043 DBMET01831 0.39 0.03 DBMET01321 0.355 0.043 DBMET01323 0.374 0.036 DBMET01324 0.487 0.01 DBMET01325 0.348 0.046 DBMET01322 | DBMET01325 | |
| 0.378 | 0.013 | 0.396 | Thrombolytic | 0.305 0.023 DBMET01830 0.285 0.027 DBMET01831 0.305 0.023 DBMET01321 0.285 0.027 DBMET01323 0.267 0.03 DBMET01324 0.396 0.012 DBMET01325 0.258 0.032 DBMET01322 | DBMET01325 | |
| 0.371 | 0.007 | 0.373 | Gastrin inhibitor | 0.347 0.011 DBMET01830 0.373 0.007 DBMET01831 0.347 0.011 DBMET01321 0.373 0.007 DBMET01323 0.318 0.022 DBMET01324 0.283 0.046 DBMET01325 0.348 0.011 DBMET01322 | DBMET01323 | |
| 0.381 | 0.018 | 0.571 | 5 Hydroxytryptamine uptake stimulant | 0.277 0.059 DBMET01830 0.391 0.016 DBMET01831 0.277 0.059 DBMET01321 0.391 0.016 DBMET01323 0.571 0.003 DBMET01324 0.285 0.053 DBMET01322 | DBMET01324 | |
| 0.359 | 0.003 | 0.359 | Integrin alpha4 antagonist | 0.257 0.004 DBMET01830 0.291 0.004 DBMET01831 0.257 0.004 DBMET01321 0.291 0.004 DBMET01323 0.265 0.004 DBMET01324 0.024 0.019 DBMET01325 0.207 0.004 DBMET01322 | ||
| 0.37 | 0.015 | 0.37 | Diuretic | 0.206 0.042 DBMET01830 0.206 0.042 DBMET01321 0.162 0.067 DBMET01324 0.323 0.019 DBMET01325 | ||
| 0.378 | 0.025 | 0.378 | Sodium/bile acid cotransporter inhibitor | 0.371 0.028 DBMET01830 0.313 0.067 DBMET01831 0.371 0.028 DBMET01321 0.313 0.067 DBMET01323 0.284 0.094 DBMET01324 0.31 0.071 DBMET01325 0.309 0.071 DBMET01322 | ||
| 0.361 | 0.017 | 0.43 | Platelet adhesion inhibitor | 0.283 0.039 DBMET01830 0.2 0.071 DBMET01831 0.283 0.039 DBMET01321 0.2 0.071 DBMET01323 0.292 0.037 DBMET01324 0.43 0.009 DBMET01325 0.373 0.015 DBMET01322 | DBMET01325 | |
| 0.364 | 0.025 | 0.444 | Interleukin agonist | 0.342 0.031 DBMET01830 0.297 0.049 DBMET01831 0.342 0.031 DBMET01321 0.297 0.049 DBMET01323 0.303 0.047 DBMET01324 0.444 0.013 DBMET01325 0.277 0.06 DBMET01322 | DBMET01325 | |
| 0.357 | 0.032 | 0.357 | Insulysin inhibitor | 0.317 0.049 DBMET01830 0.331 0.042 DBMET01831 0.317 0.049 DBMET01321 0.331 0.042 DBMET01323 0.345 0.036 DBMET01324 0.284 0.069 DBMET01322 | ||
| 0.39 | 0.067 | 0.39 | Calpain 2 inhibitor | 0.33 0.096 DBMET01830 0.245 0.153 DBMET01831 0.33 0.096 DBMET01321 0.245 0.153 DBMET01323 0.273 0.133 DBMET01324 | ||
| 0.34 | 0.025 | 0.449 | Anesthetic general | 0.258 0.047 DBMET01830 0.19 0.08 DBMET01831 0.258 0.047 DBMET01321 0.19 0.08 DBMET01323 0.143 0.121 DBMET01324 0.449 0.011 DBMET01325 0.195 0.077 DBMET01322 | DBMET01325 | |
| 0.333 | 0.02 | 0.333 | Calpain inhibitor | 0.291 0.035 DBMET01830 0.278 0.042 DBMET01831 0.291 0.035 DBMET01321 0.278 0.042 DBMET01323 0.276 0.044 DBMET01324 0.252 0.063 DBMET01325 0.251 0.064 DBMET01322 | ||
| 0.367 | 0.059 | 0.605 | Immunostimulant | 0.313 0.075 DBMET01830 0.316 0.074 DBMET01831 0.313 0.075 DBMET01321 0.316 0.074 DBMET01323 0.386 0.054 DBMET01324 0.605 0.016 DBMET01325 0.414 0.046 DBMET01322 | DBMET01325 | |
| 0.34 | 0.039 | 0.34 | Superoxide dismutase inhibitor | 0.318 0.044 DBMET01830 0.225 0.093 DBMET01831 0.318 0.044 DBMET01321 0.225 0.093 DBMET01323 0.248 0.075 DBMET01324 0.213 0.104 DBMET01322 | ||
| 0.367 | 0.074 | 0.642 | Toll-Like receptor agonist | 0.284 0.121 DBMET01830 0.642 0.013 DBMET01831 0.284 0.121 DBMET01321 0.642 0.013 DBMET01323 0.214 0.185 DBMET01324 0.499 0.032 DBMET01322 | DBMET01323 | |
| 0.309 | 0.018 | 0.309 | Thiol protease inhibitor | 0.288 0.02 DBMET01830 0.239 0.029 DBMET01831 0.288 0.02 DBMET01321 0.239 0.029 DBMET01323 0.243 0.028 DBMET01324 0.221 0.033 DBMET01322 | ||
| 0.304 | 0.014 | 0.304 | Antipruritic | 0.199 0.049 DBMET01830 0.287 0.017 DBMET01831 0.199 0.049 DBMET01321 0.287 0.017 DBMET01323 0.139 0.108 DBMET01325 0.19 0.056 DBMET01322 | ||
| 0.348 | 0.06 | 0.551 | Immunomodulator | 0.35 0.059 DBMET01830 0.411 0.041 DBMET01831 0.35 0.059 DBMET01321 0.411 0.041 DBMET01323 0.231 0.131 DBMET01324 0.551 0.017 DBMET01325 0.256 0.11 DBMET01322 | DBMET01325 | |
| 0.361 | 0.074 | 0.761 | Transcription factor NF kappa B inhibitor | 0.313 0.088 DBMET01830 0.3 0.094 DBMET01831 0.313 0.088 DBMET01321 0.3 0.094 DBMET01323 0.3 0.094 DBMET01324 0.761 0.015 DBMET01325 0.266 0.116 DBMET01322 | DBMET01325 | |
| 0.362 | 0.08 | 0.532 | Immunosuppressant | 0.396 0.065 DBMET01830 0.371 0.076 DBMET01831 0.396 0.065 DBMET01321 0.371 0.076 DBMET01323 0.441 0.05 DBMET01324 0.532 0.025 DBMET01325 0.291 0.121 DBMET01322 | DBMET01325 | |
| 0.338 | 0.062 | 0.434 | Apoptosis antagonist | 0.287 0.094 DBMET01830 0.31 0.079 DBMET01831 0.287 0.094 DBMET01321 0.31 0.079 DBMET01323 0.381 0.044 DBMET01324 0.434 0.03 DBMET01325 0.284 0.096 DBMET01322 | DBMET01325 | |
| 0.283 | 0.012 | 0.283 | Proteasome inhibitor | 0.238 0.017 DBMET01830 0.214 0.021 DBMET01831 0.238 0.017 DBMET01321 0.214 0.021 DBMET01323 0.223 0.019 DBMET01324 0.124 0.062 DBMET01325 0.201 0.025 DBMET01322 | ||
| 0.344 | 0.085 | 0.643 | Toll-Like receptor 7 agonist | 0.279 0.124 DBMET01830 0.643 0.013 DBMET01831 0.279 0.124 DBMET01321 0.643 0.013 DBMET01323 0.216 0.183 DBMET01324 0.496 0.032 DBMET01322 | DBMET01323 | |
| 0.277 | 0.019 | 0.336 | Alpha-N-acetylglucosaminidase inhibitor | 0.293 0.017 DBMET01830 0.245 0.024 DBMET01831 0.293 0.017 DBMET01321 0.245 0.024 DBMET01323 0.216 0.03 DBMET01324 0.336 0.013 DBMET01325 0.259 0.021 DBMET01322 | DBMET01325 | |
| 0.336 | 0.08 | 0.336 | Vasodilator, peripheral | 0.309 0.093 DBMET01830 0.272 0.112 DBMET01831 0.309 0.093 DBMET01321 0.272 0.112 DBMET01323 0.223 0.151 DBMET01324 0.267 0.115 DBMET01325 0.248 0.129 DBMET01322 | ||
| 0.304 | 0.048 | 0.467 | Hypolipemic | 0.467 0.015 DBMET01830 0.177 0.112 DBMET01831 0.467 0.015 DBMET01321 0.177 0.112 DBMET01323 0.336 0.039 DBMET01325 0.152 0.134 DBMET01322 | DBMET01321 | |
| 0.274 | 0.021 | 0.274 | Phospholipase C inhibitor | 0.213 0.036 DBMET01830 0.144 0.119 DBMET01831 0.213 0.036 DBMET01321 0.144 0.119 DBMET01323 0.174 0.068 DBMET01324 0.18 0.061 DBMET01325 0.143 0.121 DBMET01322 | ||
| 0.267 | 0.018 | 0.267 | Neurotensin receptor agonist | 0.225 0.026 DBMET01830 0.227 0.025 DBMET01831 0.225 0.026 DBMET01321 0.227 0.025 DBMET01323 0.23 0.025 DBMET01324 0.19 0.041 DBMET01322 | ||
| 0.278 | 0.032 | 0.321 | Anticoagulant | 0.255 0.037 DBMET01830 0.217 0.047 DBMET01831 0.255 0.037 DBMET01321 0.217 0.047 DBMET01323 0.243 0.04 DBMET01324 0.321 0.025 DBMET01325 0.198 0.054 DBMET01322 | DBMET01325 | |
| 0.335 | 0.095 | 0.399 | Antiobesity | 0.399 0.066 DBMET01830 0.362 0.082 DBMET01831 0.399 0.066 DBMET01321 0.362 0.082 DBMET01323 0.31 0.109 DBMET01325 | DBMET01321 | |
| 0.294 | 0.055 | 0.516 | Hypoglycemic | 0.39 0.029 DBMET01830 0.366 0.034 DBMET01831 0.39 0.029 DBMET01321 0.366 0.034 DBMET01323 0.262 0.07 DBMET01324 0.516 0.014 DBMET01325 0.269 0.066 DBMET01322 | DBMET01325 | |
| 0.238 | 0.006 | 0.308 | Vanilloid 1 agonist | 0.205 0.011 DBMET01830 0.166 0.025 DBMET01831 0.205 0.011 DBMET01321 0.166 0.025 DBMET01323 0.308 0.004 DBMET01324 0.22 0.008 DBMET01325 0.164 0.027 DBMET01322 | DBMET01324 | |
| 0.277 | 0.058 | 0.584 | Angiogenesis stimulant | 0.338 0.036 DBMET01830 0.284 0.056 DBMET01831 0.338 0.036 DBMET01321 0.284 0.056 DBMET01323 0.408 0.02 DBMET01324 0.584 0.008 DBMET01325 0.291 0.053 DBMET01322 | DBMET01325 | |
| 0.23 | 0.011 | 0.481 | Cyclooxygenase 3 inhibitor | 0.196 0.02 DBMET01830 0.149 0.049 DBMET01831 0.196 0.02 DBMET01321 0.149 0.049 DBMET01323 0.147 0.05 DBMET01324 0.481 0.003 DBMET01325 0.145 0.053 DBMET01322 | DBMET01325 | |
| 0.234 | 0.015 | 0.234 | Aminopeptidase B inhibitor | 0.22 0.017 DBMET01830 0.22 0.017 DBMET01831 0.22 0.017 DBMET01321 0.22 0.017 DBMET01323 0.207 0.02 DBMET01324 0.207 0.02 DBMET01322 | ||
| 0.223 | 0.005 | 0.223 | Prolactin inhibitor | 0.184 0.012 DBMET01830 0.167 0.016 DBMET01831 0.184 0.012 DBMET01321 0.167 0.016 DBMET01323 0.161 0.018 DBMET01324 0.13 0.032 DBMET01322 | ||
| 0.22 | 0.013 | 0.22 | Falcipain 3 inhibitor | 0.203 0.017 DBMET01830 0.219 0.013 DBMET01831 0.203 0.017 DBMET01321 0.219 0.013 DBMET01323 0.192 0.02 DBMET01324 0.201 0.017 DBMET01322 | ||
| 0.206 | 0.004 | 0.206 | VLA-4 antagonist | 0.149 0.004 DBMET01830 0.174 0.004 DBMET01831 0.149 0.004 DBMET01321 0.174 0.004 DBMET01323 0.156 0.004 DBMET01324 0.138 0.004 DBMET01322 | ||
| 0.196 | 0.003 | 0.196 | Integrin alpha4beta7 antagonist | 0.133 0.003 DBMET01830 0.159 0.003 DBMET01831 0.133 0.003 DBMET01321 0.159 0.003 DBMET01323 0.139 0.003 DBMET01324 0.028 0.01 DBMET01325 0.117 0.003 DBMET01322 | ||
| 0.21 | 0.019 | 0.21 | GABA C receptor agonist | 0.123 0.047 DBMET01830 0.184 0.024 DBMET01831 0.123 0.047 DBMET01321 0.184 0.024 DBMET01323 0.161 0.03 DBMET01324 0.108 0.059 DBMET01322 | ||
| 0.327 | 0.137 | 0.327 | 5 Hydroxytryptamine release inhibitor | 0.316 0.148 DBMET01830 0.32 0.144 DBMET01831 0.316 0.148 DBMET01321 0.32 0.144 DBMET01323 0.263 0.211 DBMET01324 0.282 0.186 DBMET01325 0.309 0.155 DBMET01322 | ||
| 0.215 | 0.028 | 0.441 | Hemostatic | 0.183 0.041 DBMET01830 0.152 0.066 DBMET01831 0.183 0.041 DBMET01321 0.152 0.066 DBMET01323 0.146 0.073 DBMET01324 0.441 0.005 DBMET01325 0.129 0.097 DBMET01322 | DBMET01325 | |
| 0.231 | 0.047 | 0.274 | Insulin sensitizer | 0.221 0.054 DBMET01830 0.223 0.052 DBMET01831 0.221 0.054 DBMET01321 0.223 0.052 DBMET01323 0.274 0.023 DBMET01324 0.213 0.061 DBMET01322 | DBMET01324 | |
| 0.314 | 0.131 | 0.314 | Analgesic | 0.236 0.196 DBMET01831 0.236 0.196 DBMET01323 | ||
| 0.282 | 0.103 | 0.41 | Vasodilator, coronary | 0.237 0.147 DBMET01830 0.237 0.147 DBMET01321 0.41 0.032 DBMET01325 | DBMET01325 | |
| 0.211 | 0.037 | 0.325 | Interferon gamma antagonist | 0.16 0.066 DBMET01830 0.15 0.078 DBMET01831 0.16 0.066 DBMET01321 0.15 0.078 DBMET01323 0.169 0.058 DBMET01324 0.325 0.017 DBMET01325 0.137 0.098 DBMET01322 | DBMET01325 | |
| 0.18 | 0.008 | 0.18 | Aminopeptidase I inhibitor | 0.175 0.009 DBMET01830 0.167 0.01 DBMET01831 0.175 0.009 DBMET01321 0.167 0.01 DBMET01323 0.154 0.012 DBMET01324 0.162 0.011 DBMET01322 | ||
| 0.191 | 0.025 | 0.191 | Cathepsin H inhibitor | 0.156 0.042 DBMET01830 0.176 0.031 DBMET01831 0.156 0.042 DBMET01321 0.176 0.031 DBMET01323 0.162 0.038 DBMET01324 0.142 0.053 DBMET01322 | ||
| 0.178 | 0.014 | 0.178 | Folate antagonist | 0.161 0.019 DBMET01830 0.148 0.023 DBMET01831 0.161 0.019 DBMET01321 0.148 0.023 DBMET01323 0.132 0.03 DBMET01324 0.106 0.055 DBMET01325 0.133 0.03 DBMET01322 | ||
| 0.234 | 0.072 | 0.238 | Neuropeptide Y2 antagonist | 0.203 0.114 DBMET01830 0.238 0.068 DBMET01831 0.203 0.114 DBMET01321 0.238 0.068 DBMET01323 0.207 0.108 DBMET01322 | DBMET01323 | |
| 0.178 | 0.017 | 0.186 | Papain-like protease (SARS coronavirus) inhibitor | 0.157 0.028 DBMET01830 0.177 0.017 DBMET01831 0.157 0.028 DBMET01321 0.177 0.017 DBMET01323 0.186 0.014 DBMET01324 0.129 0.061 DBMET01325 0.157 0.028 DBMET01322 | DBMET01324 | |
| 0.245 | 0.091 | 0.282 | 5 Hydroxytryptamine release stimulant | 0.168 0.156 DBMET01830 0.206 0.116 DBMET01831 0.168 0.156 DBMET01321 0.206 0.116 DBMET01323 0.282 0.076 DBMET01324 0.183 0.138 DBMET01325 | DBMET01324 | |
| 0.245 | 0.093 | 0.364 | Spasmolytic | 0.265 0.085 DBMET01830 0.255 0.089 DBMET01831 0.265 0.085 DBMET01321 0.255 0.089 DBMET01323 0.194 0.125 DBMET01324 0.364 0.048 DBMET01325 0.271 0.082 DBMET01322 | DBMET01325 | |
| 0.158 | 0.009 | 0.4 | Vanilloid agonist | 0.105 0.028 DBMET01830 0.085 0.056 DBMET01831 0.105 0.028 DBMET01321 0.085 0.056 DBMET01323 0.4 0.004 DBMET01324 0.121 0.018 DBMET01325 0.083 0.061 DBMET01322 | DBMET01324 | |
| 0.156 | 0.01 | 0.156 | Glutamate (mGluR7) agonist | 0.131 0.021 DBMET01830 0.123 0.028 DBMET01831 0.131 0.021 DBMET01321 0.123 0.028 DBMET01323 0.109 0.045 DBMET01324 0.103 0.054 DBMET01322 | ||
| 0.166 | 0.021 | 0.166 | Opioid antagonist | 0.103 0.046 DBMET01830 0.119 0.037 DBMET01831 0.103 0.046 DBMET01321 0.119 0.037 DBMET01323 0.093 0.054 DBMET01324 0.093 0.053 DBMET01325 0.082 0.066 DBMET01322 | ||
| 0.201 | 0.058 | 0.264 | Growth hormone agonist | 0.191 0.062 DBMET01830 0.213 0.054 DBMET01831 0.191 0.062 DBMET01321 0.213 0.054 DBMET01323 0.264 0.04 DBMET01324 0.201 0.058 DBMET01322 | DBMET01324 | |
| 0.187 | 0.047 | 0.229 | Melanin inhibitor | 0.153 0.078 DBMET01830 0.146 0.087 DBMET01831 0.153 0.078 DBMET01321 0.146 0.087 DBMET01323 0.195 0.043 DBMET01324 0.229 0.032 DBMET01325 0.136 0.103 DBMET01322 | DBMET01325 | |
| 0.157 | 0.018 | 0.157 | DOPA decarboxylase inhibitor | 0.138 0.029 DBMET01830 0.146 0.023 DBMET01831 0.138 0.029 DBMET01321 0.146 0.023 DBMET01323 0.136 0.03 DBMET01324 0.128 0.037 DBMET01322 | ||
| 0.159 | 0.022 | 0.159 | Caspase 3 inhibitor | 0.145 0.032 DBMET01830 0.127 0.05 DBMET01831 0.145 0.032 DBMET01321 0.127 0.05 DBMET01323 0.117 0.065 DBMET01324 0.113 0.07 DBMET01322 | ||
| 0.204 | 0.067 | 0.386 | Non-steroidal antiinflammatory agent | 0.197 0.073 DBMET01831 0.197 0.073 DBMET01323 0.386 0.015 DBMET01325 | DBMET01325 | |
| 0.182 | 0.05 | 0.182 | Catenin beta inhibitor | 0.17 0.067 DBMET01830 0.166 0.073 DBMET01831 0.17 0.067 DBMET01321 0.166 0.073 DBMET01323 0.166 0.074 DBMET01324 0.155 0.094 DBMET01322 | ||
| 0.151 | 0.021 | 0.151 | Cathepsin G inhibitor | 0.103 0.032 DBMET01830 0.088 0.038 DBMET01831 0.103 0.032 DBMET01321 0.088 0.038 DBMET01323 0.074 0.049 DBMET01324 | ||
| 0.158 | 0.028 | 0.277 | Mucolytic | 0.152 0.031 DBMET01830 0.277 0.005 DBMET01831 0.152 0.031 DBMET01321 0.277 0.005 DBMET01323 0.177 0.02 DBMET01324 0.111 0.064 DBMET01325 0.223 0.009 DBMET01322 | DBMET01323 | |
| 0.132 | 0.003 | 0.311 | Glutamate (mGluR1) agonist | 0.091 0.004 DBMET01830 0.095 0.004 DBMET01831 0.091 0.004 DBMET01321 0.095 0.004 DBMET01323 0.311 0.002 DBMET01324 0.051 0.005 DBMET01322 | DBMET01324 | |
| 0.229 | 0.103 | 0.252 | Transcription factor STAT inhibitor | 0.252 0.085 DBMET01831 0.252 0.085 DBMET01323 0.199 0.14 DBMET01324 | DBMET01323 | |
| 0.142 | 0.017 | 0.142 | Analgesic, opioid | 0.09 0.037 DBMET01830 0.108 0.028 DBMET01831 0.09 0.037 DBMET01321 0.108 0.028 DBMET01323 0.095 0.034 DBMET01325 0.069 0.062 DBMET01322 | ||
| 0.15 | 0.026 | 0.169 | Catalase inhibitor | 0.16 0.024 DBMET01830 0.16 0.024 DBMET01831 0.16 0.024 DBMET01321 0.16 0.024 DBMET01323 0.073 0.052 DBMET01324 0.169 0.022 DBMET01322 | DBMET01322 | |
| 0.156 | 0.033 | 0.274 | Expectorant | 0.115 0.054 DBMET01830 0.274 0.01 DBMET01831 0.115 0.054 DBMET01321 0.274 0.01 DBMET01323 0.248 0.013 DBMET01324 0.24 0.014 DBMET01325 0.205 0.019 DBMET01322 | DBMET01323 | |
| 0.135 | 0.012 | 0.135 | Carbonic anhydrase stimulant | 0.087 0.023 DBMET01830 0.095 0.02 DBMET01831 0.087 0.023 DBMET01321 0.095 0.02 DBMET01323 0.08 0.026 DBMET01324 0.061 0.039 DBMET01322 | ||
| 0.131 | 0.009 | 0.131 | Opioid agonist | 0.059 0.03 DBMET01830 0.048 0.042 DBMET01831 0.059 0.03 DBMET01321 0.048 0.042 DBMET01323 0.063 0.027 DBMET01325 | ||
| 0.129 | 0.011 | 0.129 | Endothelin-converting enzyme inhibitor | 0.089 0.016 DBMET01830 0.106 0.014 DBMET01831 0.089 0.016 DBMET01321 0.106 0.014 DBMET01323 0.087 0.016 DBMET01324 0.074 0.019 DBMET01322 | ||
| 0.159 | 0.042 | 0.164 | Protein-tyrosine phosphatase 1B inhibitor | 0.101 0.077 DBMET01830 0.114 0.067 DBMET01831 0.101 0.077 DBMET01321 0.114 0.067 DBMET01323 0.164 0.04 DBMET01324 0.152 0.044 DBMET01325 | DBMET01324 | |
| 0.175 | 0.059 | 0.175 | Protein-tyrosine phosphatase inhibitor | 0.122 0.112 DBMET01830 0.136 0.095 DBMET01831 0.122 0.112 DBMET01321 0.136 0.095 DBMET01323 0.174 0.06 DBMET01324 0.154 0.074 DBMET01325 | ||
| 0.127 | 0.012 | 0.127 | NMDA receptor agonist | 0.099 0.02 DBMET01830 0.076 0.032 DBMET01831 0.099 0.02 DBMET01321 0.076 0.032 DBMET01323 0.058 0.05 DBMET01322 | ||
| 0.135 | 0.021 | 0.135 | Opioid mu receptor antagonist | 0.076 0.042 DBMET01830 0.089 0.036 DBMET01831 0.076 0.042 DBMET01321 0.089 0.036 DBMET01323 0.07 0.046 DBMET01324 0.07 0.046 DBMET01325 | ||
| 0.315 | 0.201 | 0.715 | Antiinflammatory | 0.311 0.205 DBMET01830 0.508 0.084 DBMET01831 0.311 0.205 DBMET01321 0.508 0.084 DBMET01323 0.543 0.071 DBMET01324 0.715 0.028 DBMET01325 0.672 0.036 DBMET01322 | DBMET01325 | |
| 0.122 | 0.009 | 0.122 | Erythropoietin receptor agonist | 0.09 0.011 DBMET01830 0.074 0.014 DBMET01831 0.09 0.011 DBMET01321 0.074 0.014 DBMET01323 0.067 0.015 DBMET01324 0.063 0.016 DBMET01322 | ||
| 0.117 | 0.003 | 0.117 | Integrin beta7 antagonist | 0.102 0.004 DBMET01830 0.111 0.003 DBMET01831 0.102 0.004 DBMET01321 0.111 0.003 DBMET01323 0.104 0.004 DBMET01324 0.098 0.004 DBMET01322 | ||
| 0.117 | 0.004 | 0.117 | Nociceptin (N/OFQ) receptor agonist | 0.04 0.007 DBMET01830 0.04 0.007 DBMET01321 0.024 0.012 DBMET01325 | ||
| 0.133 | 0.021 | 0.133 | Chymotrypsin inhibitor | 0.1 0.036 DBMET01830 0.096 0.039 DBMET01831 0.1 0.036 DBMET01321 0.096 0.039 DBMET01323 0.117 0.027 DBMET01324 0.086 0.047 DBMET01322 | ||
| 0.148 | 0.039 | 0.244 | Microtubule formation inhibitor | 0.11 0.074 DBMET01830 0.107 0.078 DBMET01831 0.11 0.074 DBMET01321 0.107 0.078 DBMET01323 0.134 0.048 DBMET01324 0.244 0.01 DBMET01325 | DBMET01325 | |
| 0.111 | 0.004 | 0.111 | VCAM antagonist | 0.076 0.005 DBMET01830 0.105 0.004 DBMET01831 0.076 0.005 DBMET01321 0.105 0.004 DBMET01323 0.093 0.004 DBMET01324 0.037 0.036 DBMET01325 0.074 0.005 DBMET01322 | ||
| 0.159 | 0.052 | 0.202 | Bone formation stimulant | 0.151 0.058 DBMET01830 0.182 0.041 DBMET01831 0.151 0.058 DBMET01321 0.182 0.041 DBMET01323 0.202 0.035 DBMET01324 0.14 0.067 DBMET01325 0.169 0.046 DBMET01322 | DBMET01324 | |
| 0.141 | 0.034 | 0.141 | Protease inhibitor | 0.128 0.042 DBMET01830 0.138 0.036 DBMET01831 0.128 0.042 DBMET01321 0.138 0.036 DBMET01323 0.134 0.038 DBMET01324 0.11 0.056 DBMET01325 0.126 0.043 DBMET01322 | ||
| 0.107 | 0.003 | 0.107 | Integrin alpha1beta1 antagonist | 0.087 0.003 DBMET01830 0.1 0.003 DBMET01831 0.087 0.003 DBMET01321 0.1 0.003 DBMET01323 0.1 0.003 DBMET01324 0.047 0.009 DBMET01325 0.083 0.003 DBMET01322 | ||
| 0.128 | 0.024 | 0.128 | Opioid delta receptor antagonist | 0.068 0.041 DBMET01830 0.103 0.029 DBMET01831 0.068 0.041 DBMET01321 0.103 0.029 DBMET01323 0.081 0.036 DBMET01324 0.058 0.048 DBMET01322 | ||
| 0.135 | 0.032 | 0.147 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.104 0.05 DBMET01830 0.117 0.041 DBMET01831 0.104 0.05 DBMET01321 0.117 0.041 DBMET01323 0.147 0.027 DBMET01324 0.099 0.055 DBMET01325 0.091 0.064 DBMET01322 | DBMET01324 | |
| 0.141 | 0.038 | 0.141 | Nav1.4 sodium channel blocker | 0.115 0.057 DBMET01830 0.096 0.082 DBMET01831 0.115 0.057 DBMET01321 0.096 0.082 DBMET01323 | ||
| 0.111 | 0.009 | 0.111 | Phospholipase D inhibitor | 0.098 0.016 DBMET01830 0.089 0.023 DBMET01831 0.098 0.016 DBMET01321 0.089 0.023 DBMET01323 0.086 0.026 DBMET01324 0.079 0.037 DBMET01322 | ||
| 0.157 | 0.055 | 0.157 | Neuropeptide Y1 antagonist | |||
| 0.127 | 0.026 | 0.127 | ABCA1 expression enhancer | 0.116 0.033 DBMET01830 0.114 0.035 DBMET01831 0.116 0.033 DBMET01321 0.114 0.035 DBMET01323 0.094 0.059 DBMET01324 0.105 0.044 DBMET01322 | ||
| 0.104 | 0.004 | 0.104 | VCAM-1 antagonist | 0.074 0.005 DBMET01830 0.099 0.004 DBMET01831 0.074 0.005 DBMET01321 0.099 0.004 DBMET01323 0.088 0.004 DBMET01324 0.071 0.005 DBMET01322 | ||
| 0.124 | 0.025 | 0.164 | Glutamate receptor agonist | 0.164 0.015 DBMET01831 0.164 0.015 DBMET01323 | DBMET01323 | |
| 0.101 | 0.004 | 0.101 | Integrin alpha4beta1 antagonist | 0.047 0.005 DBMET01830 0.043 0.005 DBMET01831 0.047 0.005 DBMET01321 0.043 0.005 DBMET01323 0.027 0.008 DBMET01324 0.02 0.009 DBMET01322 | ||
| 0.103 | 0.007 | 0.103 | Diacylglycerol O-acyltransferase inhibitor | 0.072 0.018 DBMET01830 0.068 0.021 DBMET01831 0.072 0.018 DBMET01321 0.068 0.021 DBMET01323 0.055 0.03 DBMET01324 0.055 0.03 DBMET01322 | ||
| 0.275 | 0.18 | 0.275 | Calcium channel L-type activator | 0.248 0.207 DBMET01830 0.248 0.207 DBMET01831 0.248 0.207 DBMET01321 0.248 0.207 DBMET01323 0.231 0.228 DBMET01322 | ||
| 0.153 | 0.059 | 0.169 | Adenylate cyclase stimulant | 0.143 0.076 DBMET01830 0.16 0.048 DBMET01831 0.143 0.076 DBMET01321 0.16 0.048 DBMET01323 0.169 0.036 DBMET01324 0.15 0.063 DBMET01322 | DBMET01324 | |
| 0.136 | 0.042 | 0.166 | TRPA1 agonist | 0.166 0.021 DBMET01324 | DBMET01324 | |
| 0.143 | 0.05 | 0.143 | Adenylate cyclase inhibitor | 0.128 0.061 DBMET01830 0.115 0.072 DBMET01831 0.128 0.061 DBMET01321 0.115 0.072 DBMET01323 0.138 0.054 DBMET01324 0.096 0.087 DBMET01322 | ||
| 0.097 | 0.004 | 0.097 | Membrane dipeptidase inhibitor | 0.079 0.005 DBMET01830 0.086 0.005 DBMET01831 0.079 0.005 DBMET01321 0.086 0.005 DBMET01323 0.09 0.004 DBMET01324 0.07 0.007 DBMET01322 | ||
| 0.171 | 0.079 | 0.171 | Lipocortins synthesis antagonist | 0.162 0.089 DBMET01830 0.158 0.094 DBMET01831 0.162 0.089 DBMET01321 0.158 0.094 DBMET01323 0.141 0.119 DBMET01325 0.151 0.103 DBMET01322 | ||
| 0.134 | 0.043 | 0.134 | Photosensitizer | 0.102 0.086 DBMET01830 0.102 0.086 DBMET01321 0.11 0.072 DBMET01324 0.134 0.043 DBMET01325 | ||
| 0.141 | 0.05 | 0.174 | Cholesterol synthesis inhibitor | 0.174 0.034 DBMET01830 0.138 0.051 DBMET01831 0.174 0.034 DBMET01321 0.138 0.051 DBMET01323 0.096 0.093 DBMET01325 0.133 0.055 DBMET01322 | DBMET01321 | |
| 0.103 | 0.013 | 0.103 | Opioid mu receptor agonist | 0.05 0.029 DBMET01830 0.056 0.025 DBMET01831 0.05 0.029 DBMET01321 0.056 0.025 DBMET01323 0.046 0.033 DBMET01324 0.049 0.029 DBMET01325 0.044 0.035 DBMET01322 | ||
| 0.114 | 0.025 | 0.114 | Bile acid receptor antagonist | 0.106 0.037 DBMET01830 0.106 0.037 DBMET01321 | ||
| 0.093 | 0.004 | 0.093 | Glutamate (mGluR1a) agonist | 0.048 0.005 DBMET01830 0.065 0.004 DBMET01831 0.048 0.005 DBMET01321 0.065 0.004 DBMET01323 0.046 0.005 DBMET01324 0.036 0.007 DBMET01322 | ||
| 0.122 | 0.034 | 0.122 | Interleukin 1 beta converting enzyme inhibitor | 0.098 0.06 DBMET01830 0.088 0.075 DBMET01831 0.098 0.06 DBMET01321 0.088 0.075 DBMET01323 0.094 0.066 DBMET01324 | ||
| 0.106 | 0.019 | 0.106 | Glucagon-like peptide 1 agonist | 0.103 0.02 DBMET01830 0.099 0.022 DBMET01831 0.103 0.02 DBMET01321 0.099 0.022 DBMET01323 0.094 0.025 DBMET01324 0.097 0.023 DBMET01322 | ||
| 0.106 | 0.018 | 0.106 | Ribonucleoside-diphosphate reductase inhibitor | 0.092 0.021 DBMET01830 0.069 0.03 DBMET01831 0.092 0.021 DBMET01321 0.069 0.03 DBMET01323 0.073 0.027 DBMET01324 0.059 0.035 DBMET01322 | ||
| 0.091 | 0.005 | 0.091 | Glutamate (mGluR3) antagonist | 0.048 0.014 DBMET01830 0.051 0.012 DBMET01831 0.048 0.014 DBMET01321 0.051 0.012 DBMET01323 0.036 0.026 DBMET01324 0.038 0.024 DBMET01322 | ||
| 0.09 | 0.004 | 0.09 | Lysine carboxypeptidase inhibitor | 0.079 0.004 DBMET01830 0.036 0.012 DBMET01831 0.079 0.004 DBMET01321 0.036 0.012 DBMET01323 0.032 0.015 DBMET01324 0.033 0.014 DBMET01322 | ||
| 0.089 | 0.005 | 0.095 | Prostacyclin antagonist | 0.095 0.005 DBMET01830 0.075 0.006 DBMET01831 0.095 0.005 DBMET01321 0.075 0.006 DBMET01323 0.074 0.006 DBMET01324 0.068 0.007 DBMET01322 | DBMET01321 | |
| 0.102 | 0.02 | 0.102 | Ribonucleotide reductase inhibitor | 0.09 0.023 DBMET01830 0.068 0.032 DBMET01831 0.09 0.023 DBMET01321 0.068 0.032 DBMET01323 0.072 0.03 DBMET01324 0.059 0.037 DBMET01322 | ||
| 0.101 | 0.02 | 0.101 | CC chemokine 5 receptor agonist | 0.082 0.056 DBMET01830 0.082 0.057 DBMET01831 0.082 0.056 DBMET01321 0.082 0.057 DBMET01323 0.084 0.05 DBMET01324 | ||
| 0.1 | 0.02 | 0.1 | Cathepsin L inhibitor | 0.069 0.031 DBMET01830 0.059 0.04 DBMET01831 0.069 0.031 DBMET01321 0.059 0.04 DBMET01323 | ||
| 0.085 | 0.006 | 0.085 | AMPA 4 receptor antagonist | 0.047 0.017 DBMET01830 0.047 0.017 DBMET01321 0.077 0.007 DBMET01324 | ||
| 0.085 | 0.006 | 0.085 | Integrin alpha5beta1 antagonist | 0.069 0.009 DBMET01830 0.068 0.009 DBMET01831 0.069 0.009 DBMET01321 0.068 0.009 DBMET01323 0.062 0.011 DBMET01324 0.058 0.013 DBMET01322 | ||
| 0.108 | 0.031 | 0.108 | Factor XII inhibitor | 0.1 0.037 DBMET01830 0.098 0.04 DBMET01831 0.1 0.037 DBMET01321 0.098 0.04 DBMET01323 0.095 0.042 DBMET01324 0.09 0.049 DBMET01322 | ||
| 0.157 | 0.08 | 0.163 | Arachidonic acid antagonist | 0.163 0.073 DBMET01830 0.135 0.106 DBMET01831 0.163 0.073 DBMET01321 0.135 0.106 DBMET01323 0.143 0.097 DBMET01324 0.142 0.098 DBMET01322 | DBMET01321 | |
| 0.095 | 0.019 | 0.095 | Peroxisome proliferator-activated receptor gamma antagonist | 0.086 0.026 DBMET01830 0.084 0.029 DBMET01831 0.086 0.026 DBMET01321 0.084 0.029 DBMET01323 0.074 0.044 DBMET01324 0.076 0.04 DBMET01322 | ||
| 0.095 | 0.019 | 0.095 | GP IIb/IIIa receptor antagonist | 0.068 0.025 DBMET01830 0.069 0.025 DBMET01831 0.068 0.025 DBMET01321 0.069 0.025 DBMET01323 0.063 0.027 DBMET01324 0.053 0.031 DBMET01322 | ||
| 0.085 | 0.009 | 0.085 | HCV NS3/NS4A protease inhibitor | 0.06 0.021 DBMET01830 0.064 0.018 DBMET01831 0.06 0.021 DBMET01321 0.064 0.018 DBMET01323 0.066 0.017 DBMET01324 0.05 0.032 DBMET01322 | ||
| 0.087 | 0.011 | 0.087 | Angiotensin-converting enzyme inhibitor | 0.072 0.018 DBMET01830 0.074 0.016 DBMET01831 0.072 0.018 DBMET01321 0.074 0.016 DBMET01323 0.074 0.016 DBMET01324 0.053 0.041 DBMET01325 0.068 0.022 DBMET01322 | ||
| 0.077 | 0.003 | 0.077 | Integrin beta2 antagonist | 0.057 0.003 DBMET01830 0.044 0.003 DBMET01831 0.057 0.003 DBMET01321 0.044 0.003 DBMET01323 0.019 0.005 DBMET01324 0.033 0.004 DBMET01322 | ||
| 0.142 | 0.069 | 0.142 | Histone deacetylase SIRT1 inhibitor | 0.123 0.088 DBMET01830 0.134 0.076 DBMET01831 0.123 0.088 DBMET01321 0.134 0.076 DBMET01323 0.11 0.104 DBMET01324 0.116 0.096 DBMET01322 | ||
| 0.081 | 0.007 | 0.081 | Nociceptin (N/OFQ) receptor antagonist | 0.031 0.028 DBMET01830 0.031 0.028 DBMET01321 | ||
| 0.092 | 0.019 | 0.092 | Protease 3C (Human rhinovirus) inhibitor | 0.087 0.022 DBMET01830 0.088 0.022 DBMET01831 0.087 0.022 DBMET01321 0.088 0.022 DBMET01323 0.078 0.029 DBMET01324 0.083 0.025 DBMET01322 | ||
| 0.148 | 0.076 | 0.148 | Phospholipase A2 inhibitor | 0.142 0.083 DBMET01830 0.142 0.083 DBMET01321 0.131 0.099 DBMET01325 | ||
| 0.175 | 0.104 | 0.175 | Neurotrophic factor enhancer | 0.156 0.129 DBMET01830 0.149 0.139 DBMET01831 0.156 0.129 DBMET01321 0.149 0.139 DBMET01323 0.149 0.14 DBMET01325 | ||
| 0.076 | 0.004 | 0.076 | LFA antagonist | 0.055 0.005 DBMET01830 0.066 0.005 DBMET01831 0.055 0.005 DBMET01321 0.066 0.005 DBMET01323 0.026 0.022 DBMET01324 0.047 0.006 DBMET01322 | ||
| 0.103 | 0.032 | 0.103 | Opioid kappa receptor antagonist | 0.083 0.054 DBMET01831 0.083 0.054 DBMET01323 | ||
| 0.187 | 0.117 | 0.339 | Peptidyltransferase inhibitor | 0.219 0.077 DBMET01830 0.194 0.108 DBMET01831 0.219 0.077 DBMET01321 0.194 0.108 DBMET01323 0.203 0.095 DBMET01324 0.339 0.014 DBMET01325 0.224 0.073 DBMET01322 | DBMET01325 | |
| 0.087 | 0.018 | 0.088 | Glutamate (mGluR6) antagonist | 0.078 0.027 DBMET01830 0.088 0.017 DBMET01831 0.078 0.027 DBMET01321 0.088 0.017 DBMET01323 0.083 0.021 DBMET01324 0.078 0.026 DBMET01322 | DBMET01323 | |
| 0.073 | 0.004 | 0.073 | Integrin alphaVbeta1 antagonist | 0.049 0.004 DBMET01830 0.057 0.004 DBMET01831 0.049 0.004 DBMET01321 0.057 0.004 DBMET01323 0.043 0.005 DBMET01324 0.039 0.005 DBMET01322 | ||
| 0.08 | 0.011 | 0.089 | Cathepsin L2 inhibitor | 0.059 0.018 DBMET01830 0.089 0.009 DBMET01831 0.059 0.018 DBMET01321 0.089 0.009 DBMET01323 0.057 0.019 DBMET01324 0.066 0.015 DBMET01322 | DBMET01323 | |
| 0.096 | 0.028 | 0.113 | Phenylalanine 4-hydroxylase inhibitor | 0.101 0.025 DBMET01830 0.098 0.027 DBMET01831 0.101 0.025 DBMET01321 0.098 0.027 DBMET01323 0.113 0.021 DBMET01324 0.103 0.024 DBMET01322 | DBMET01324 | |
| 0.096 | 0.028 | 0.096 | Matrix metalloproteinase inhibitor | 0.078 0.038 DBMET01830 0.078 0.038 DBMET01321 | ||
| 0.101 | 0.034 | 0.111 | Hematopoietic | 0.098 0.038 DBMET01830 0.111 0.027 DBMET01831 0.098 0.038 DBMET01321 0.111 0.027 DBMET01323 0.096 0.041 DBMET01324 0.106 0.03 DBMET01322 | DBMET01323 | |
| 0.081 | 0.016 | 0.11 | Factor IXa inhibitor | 0.071 0.02 DBMET01830 0.089 0.013 DBMET01831 0.071 0.02 DBMET01321 0.089 0.013 DBMET01323 0.05 0.038 DBMET01324 0.11 0.008 DBMET01325 0.08 0.016 DBMET01322 | DBMET01325 | |
| 0.085 | 0.02 | 0.085 | Caspase 9 inhibitor | 0.075 0.027 DBMET01830 0.072 0.029 DBMET01831 0.075 0.027 DBMET01321 0.072 0.029 DBMET01323 0.066 0.037 DBMET01324 0.065 0.038 DBMET01322 | ||
| 0.069 | 0.005 | 0.141 | Kainate receptor agonist | 0.051 0.013 DBMET01830 0.069 0.005 DBMET01831 0.051 0.013 DBMET01321 0.069 0.005 DBMET01323 0.141 0.002 DBMET01324 0.051 0.013 DBMET01322 | DBMET01324 | |
| 0.091 | 0.027 | 0.091 | Glycine receptor agonist | 0.087 0.03 DBMET01830 0.069 0.057 DBMET01831 0.087 0.03 DBMET01321 0.069 0.057 DBMET01323 0.066 0.064 DBMET01325 0.066 0.062 DBMET01322 | ||
| 0.066 | 0.003 | 0.066 | ICAM 1 antagonist | 0.051 0.004 DBMET01830 0.044 0.004 DBMET01831 0.051 0.004 DBMET01321 0.044 0.004 DBMET01323 0.027 0.009 DBMET01324 0.038 0.005 DBMET01322 | ||
| 0.07 | 0.009 | 0.07 | Carbonic anhydrase I stimulant | 0.053 0.015 DBMET01830 0.058 0.013 DBMET01831 0.053 0.015 DBMET01321 0.058 0.013 DBMET01323 0.053 0.015 DBMET01324 0.043 0.021 DBMET01322 | ||
| 0.075 | 0.014 | 0.075 | Purinergic P2Y antagonist | 0.042 0.035 DBMET01830 0.042 0.035 DBMET01321 0.044 0.032 DBMET01325 | ||
| 0.071 | 0.009 | 0.071 | Factor XIa inhibitor | 0.052 0.017 DBMET01830 0.064 0.011 DBMET01831 0.052 0.017 DBMET01321 0.064 0.011 DBMET01323 0.062 0.012 DBMET01324 0.069 0.01 DBMET01322 | ||
| 0.074 | 0.013 | 0.116 | 5-Alpha-reductase inhibitor | 0.099 0.01 DBMET01830 0.078 0.013 DBMET01831 0.099 0.01 DBMET01321 0.078 0.013 DBMET01323 0.116 0.009 DBMET01324 | DBMET01324 | |
| 0.068 | 0.008 | 0.068 | Parathyroid hormone antagonist | 0.044 0.034 DBMET01830 0.045 0.032 DBMET01831 0.044 0.034 DBMET01321 0.045 0.032 DBMET01323 0.043 0.039 DBMET01325 0.043 0.037 DBMET01322 | ||
| 0.094 | 0.034 | 0.099 | Histidine decarboxylase inhibitor | 0.099 0.032 DBMET01831 0.099 0.032 DBMET01323 0.064 0.057 DBMET01324 0.063 0.058 DBMET01322 | DBMET01323 | |
| 0.062 | 0.004 | 0.062 | Glutamate (mGluR3) agonist | 0.048 0.005 DBMET01830 0.042 0.008 DBMET01831 0.048 0.005 DBMET01321 0.042 0.008 DBMET01323 0.04 0.01 DBMET01324 0.032 0.022 DBMET01325 0.039 0.011 DBMET01322 | ||
| 0.128 | 0.07 | 0.133 | Toll-Like receptor 2 antagonist | 0.129 0.069 DBMET01830 0.112 0.087 DBMET01831 0.129 0.069 DBMET01321 0.112 0.087 DBMET01323 0.133 0.065 DBMET01324 0.113 0.086 DBMET01322 | DBMET01324 | |
| 0.139 | 0.08 | 0.139 | Heat shock protein 70 antagonist | 0.13 0.122 DBMET01830 0.129 0.126 DBMET01831 0.13 0.122 DBMET01321 0.129 0.126 DBMET01323 0.134 0.102 DBMET01324 | ||
| 0.074 | 0.016 | 0.074 | Complement C3a chemotactic receptor antagonist | 0.064 0.02 DBMET01830 0.063 0.02 DBMET01831 0.064 0.02 DBMET01321 0.063 0.02 DBMET01323 0.058 0.023 DBMET01324 0.053 0.025 DBMET01322 | ||
| 0.071 | 0.014 | 0.071 | Carbonic anhydrase II stimulant | 0.061 0.022 DBMET01830 0.064 0.019 DBMET01831 0.061 0.022 DBMET01321 0.064 0.019 DBMET01323 0.06 0.023 DBMET01324 0.056 0.029 DBMET01322 | ||
| 0.077 | 0.021 | 0.077 | NMDA 2A receptor antagonist | |||
| 0.058 | 0.004 | 0.058 | Carboxypeptidase B inhibitor | 0.048 0.008 DBMET01830 0.04 0.012 DBMET01831 0.048 0.008 DBMET01321 0.04 0.012 DBMET01323 0.037 0.016 DBMET01324 0.034 0.021 DBMET01322 | ||
| 0.073 | 0.019 | 0.15 | Phosphorylase inhibitor | 0.099 0.013 DBMET01830 0.109 0.012 DBMET01831 0.099 0.013 DBMET01321 0.109 0.012 DBMET01323 0.116 0.011 DBMET01324 0.15 0.007 DBMET01325 0.143 0.008 DBMET01322 | DBMET01325 | |
| 0.156 | 0.103 | 0.361 | Hepatoprotectant | 0.198 0.066 DBMET01831 0.198 0.066 DBMET01323 0.181 0.079 DBMET01324 0.361 0.017 DBMET01325 0.159 0.101 DBMET01322 | DBMET01325 | |
| 0.069 | 0.016 | 0.069 | Prolyl endopeptidase inhibitor | 0.06 0.025 DBMET01830 0.051 0.034 DBMET01831 0.06 0.025 DBMET01321 0.051 0.034 DBMET01323 0.061 0.023 DBMET01324 | ||
| 0.064 | 0.012 | 0.087 | Glutamate (mGluR4) antagonist | 0.049 0.021 DBMET01830 0.049 0.021 DBMET01321 0.087 0.007 DBMET01324 | DBMET01324 | |
| 0.127 | 0.076 | 0.261 | Amylase inhibitor | 0.261 0.025 DBMET01325 | DBMET01325 | |
| 0.071 | 0.02 | 0.071 | Glycine transporter 2 inhibitor | 0.048 0.032 DBMET01830 0.048 0.032 DBMET01321 | ||
| 0.088 | 0.039 | 0.088 | Metalloproteinase-9 inhibitor | 0.075 0.048 DBMET01830 0.075 0.048 DBMET01321 | ||
| 0.057 | 0.008 | 0.057 | Glucagon receptor antagonist | |||
| 0.09 | 0.041 | 0.093 | Estrogen-related receptor beta agonist | 0.093 0.036 DBMET01830 0.093 0.036 DBMET01321 | DBMET01321 | |
| 0.085 | 0.037 | 0.085 | Epoxide hydrolase inhibitor | 0.067 0.057 DBMET01830 0.065 0.061 DBMET01831 0.067 0.057 DBMET01321 0.065 0.061 DBMET01323 0.065 0.061 DBMET01324 | ||
| 0.075 | 0.027 | 0.078 | Argininosuccinate synthase inhibitor | 0.078 0.026 DBMET01831 0.078 0.026 DBMET01323 0.056 0.04 DBMET01324 0.049 0.048 DBMET01322 | DBMET01323 | |
| 0.053 | 0.005 | 0.053 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.014 DBMET01830 0.047 0.007 DBMET01831 0.041 0.014 DBMET01321 0.047 0.007 DBMET01323 0.043 0.011 DBMET01324 0.036 0.023 DBMET01322 | ||
| 0.065 | 0.018 | 0.07 | Lysophosphatidic acid 3 receptor antagonist | 0.06 0.023 DBMET01830 0.06 0.023 DBMET01831 0.06 0.023 DBMET01321 0.06 0.023 DBMET01323 0.07 0.014 DBMET01324 0.054 0.029 DBMET01322 | DBMET01324 | |
| 0.132 | 0.084 | 0.24 | Cell wall synthesis inhibitor | 0.118 0.103 DBMET01831 0.118 0.103 DBMET01323 0.24 0.018 DBMET01325 | DBMET01325 | |
| 0.091 | 0.043 | 0.091 | Metalloproteinase-2 inhibitor | 0.087 0.046 DBMET01830 0.07 0.065 DBMET01831 0.087 0.046 DBMET01321 0.07 0.065 DBMET01323 0.071 0.064 DBMET01324 | ||
| 0.091 | 0.044 | 0.098 | 3C-Like protease (SARS coronavirus) inhibitor | 0.087 0.051 DBMET01830 0.083 0.06 DBMET01831 0.087 0.051 DBMET01321 0.083 0.06 DBMET01323 0.098 0.036 DBMET01324 0.08 0.069 DBMET01322 | DBMET01324 | |
| 0.06 | 0.014 | 0.06 | AICAR transformylase inhibitor | 0.041 0.036 DBMET01830 0.044 0.03 DBMET01831 0.041 0.036 DBMET01321 0.044 0.03 DBMET01323 | ||
| 0.066 | 0.02 | 0.066 | Plasminogen activator inhibitor antagonist | |||
| 0.1 | 0.055 | 0.1 | Falcipain inhibitor | 0.078 0.077 DBMET01830 0.091 0.062 DBMET01831 0.078 0.077 DBMET01321 0.091 0.062 DBMET01323 0.082 0.071 DBMET01324 0.079 0.075 DBMET01325 | ||
| 0.1 | 0.055 | 0.1 | Lanosterol 14 alpha demethylase inhibitor | 0.094 0.065 DBMET01831 0.094 0.065 DBMET01323 | ||
| 0.063 | 0.019 | 0.063 | Immunoglobulin Fc receptor antagonist | 0.055 0.037 DBMET01830 0.055 0.037 DBMET01321 | ||
| 0.07 | 0.025 | 0.07 | Sphingosine 1-phosphate receptor 3 antagonist | 0.065 0.031 DBMET01830 0.065 0.031 DBMET01321 | ||
| 0.084 | 0.041 | 0.093 | Glutamate dehydrogenase inhibitor | 0.086 0.039 DBMET01831 0.086 0.039 DBMET01323 0.093 0.035 DBMET01324 0.065 0.064 DBMET01322 | DBMET01324 | |
| 0.128 | 0.085 | 0.152 | Protein kinase stimulant | 0.152 0.067 DBMET01325 | DBMET01325 | |
| 0.064 | 0.022 | 0.064 | Bombesin 2 receptor antagonist | 0.057 0.026 DBMET01830 0.05 0.033 DBMET01831 0.057 0.026 DBMET01321 0.05 0.033 DBMET01323 0.046 0.039 DBMET01324 0.046 0.041 DBMET01322 | ||
| 0.096 | 0.054 | 0.096 | Falcipain 2 inhibitor | 0.087 0.062 DBMET01831 0.087 0.062 DBMET01323 0.079 0.071 DBMET01324 0.076 0.075 DBMET01325 | ||
| 0.049 | 0.008 | 0.049 | Neutral endopeptidase inhibitor | 0.034 0.01 DBMET01830 0.031 0.011 DBMET01831 0.034 0.01 DBMET01321 0.031 0.011 DBMET01323 0.032 0.011 DBMET01324 0.02 0.015 DBMET01322 | ||
| 0.055 | 0.016 | 0.059 | Calcitonin receptor agonist | 0.059 0.015 DBMET01830 0.037 0.022 DBMET01831 0.059 0.015 DBMET01321 0.037 0.022 DBMET01323 0.032 0.025 DBMET01324 0.039 0.02 DBMET01322 | DBMET01321 | |
| 0.062 | 0.023 | 0.062 | Neurotensin receptor antagonist | 0.048 0.029 DBMET01830 0.051 0.027 DBMET01831 0.048 0.029 DBMET01321 0.051 0.027 DBMET01323 0.046 0.03 DBMET01324 0.042 0.034 DBMET01322 | ||
| 0.042 | 0.004 | 0.042 | Integrin alphaLbeta2 antagonist | 0.029 0.004 DBMET01830 0.024 0.005 DBMET01831 0.029 0.004 DBMET01321 0.024 0.005 DBMET01323 0.017 0.006 DBMET01324 0.019 0.005 DBMET01322 | ||
| 0.067 | 0.03 | 0.067 | Cathepsin D inhibitor | 0.054 0.038 DBMET01830 0.061 0.034 DBMET01831 0.054 0.038 DBMET01321 0.061 0.034 DBMET01323 0.055 0.038 DBMET01324 0.05 0.042 DBMET01322 | ||
| 0.056 | 0.02 | 0.056 | Opioid kappa receptor agonist | 0.041 0.032 DBMET01325 | ||
| 0.076 | 0.04 | 0.076 | Elastase 1 inhibitor | 0.068 0.05 DBMET01830 0.068 0.049 DBMET01831 0.068 0.05 DBMET01321 0.068 0.049 DBMET01323 0.066 0.052 DBMET01324 0.061 0.06 DBMET01322 | ||
| 0.068 | 0.032 | 0.068 | Cathepsin E inhibitor | 0.061 0.039 DBMET01830 0.061 0.039 DBMET01831 0.061 0.039 DBMET01321 0.061 0.039 DBMET01323 0.064 0.035 DBMET01324 0.056 0.047 DBMET01322 | ||
| 0.08 | 0.044 | 0.087 | Glutamate decarboxylase inhibitor | 0.069 0.056 DBMET01830 0.071 0.054 DBMET01831 0.069 0.056 DBMET01321 0.071 0.054 DBMET01323 0.087 0.038 DBMET01324 | DBMET01324 | |
| 0.072 | 0.037 | 0.072 | Neutrophil collagenase inhibitor | 0.06 0.051 DBMET01830 0.06 0.051 DBMET01321 | ||
| 0.071 | 0.036 | 0.071 | MDM2 inhibitor | |||
| 0.065 | 0.031 | 0.065 | Cathepsin B inhibitor | 0.054 0.042 DBMET01830 0.055 0.041 DBMET01831 0.054 0.042 DBMET01321 0.055 0.041 DBMET01323 0.054 0.043 DBMET01324 0.05 0.049 DBMET01322 | ||
| 0.059 | 0.025 | 0.059 | Metalloproteinase-3 inhibitor | 0.051 0.032 DBMET01830 0.052 0.03 DBMET01831 0.051 0.032 DBMET01321 0.052 0.03 DBMET01323 0.051 0.031 DBMET01324 0.045 0.039 DBMET01322 | ||
| 0.059 | 0.027 | 0.059 | Dipeptidyl peptidase inhibitor | |||
| 0.051 | 0.019 | 0.063 | Glutamate (mGluR group III) antagonist | 0.041 0.038 DBMET01830 0.041 0.038 DBMET01321 0.063 0.011 DBMET01324 | DBMET01324 | |
| 0.104 | 0.072 | 0.162 | GABA C receptor antagonist | 0.141 0.035 DBMET01831 0.141 0.035 DBMET01323 0.162 0.024 DBMET01324 | DBMET01324 | |
| 0.062 | 0.031 | 0.062 | Matrix metalloproteinase (membrane-type) inhibitor | 0.051 0.044 DBMET01830 0.051 0.044 DBMET01321 | ||
| 0.045 | 0.015 | 0.045 | Integrin alpha2 antagonist | 0.035 0.029 DBMET01830 0.045 0.015 DBMET01831 0.035 0.029 DBMET01321 0.045 0.015 DBMET01323 0.043 0.018 DBMET01324 0.035 0.03 DBMET01322 | ||
| 0.185 | 0.156 | 0.299 | Transcription factor STAT3 inhibitor | 0.299 0.054 DBMET01831 0.299 0.054 DBMET01323 0.241 0.091 DBMET01324 0.221 0.11 DBMET01322 | DBMET01323 | |
| 0.078 | 0.049 | 0.08 | GABA aminotransferase inhibitor | 0.07 0.061 DBMET01831 0.07 0.061 DBMET01323 0.08 0.047 DBMET01324 0.074 0.055 DBMET01325 | DBMET01324 | |
| 0.108 | 0.08 | 0.108 | Interleukin 8 antagonist | |||
| 0.046 | 0.017 | 0.046 | Aggrecanase 1 inhibitor | 0.04 0.026 DBMET01830 0.04 0.026 DBMET01321 | ||
| 0.042 | 0.014 | 0.042 | Glutamate (mGluR8) antagonist | 0.037 0.022 DBMET01830 0.041 0.016 DBMET01831 0.037 0.022 DBMET01321 0.041 0.016 DBMET01323 0.039 0.018 DBMET01324 0.036 0.025 DBMET01322 | ||
| 0.124 | 0.096 | 0.124 | Farnesoid X receptor antagonist | 0.121 0.101 DBMET01830 0.116 0.113 DBMET01831 0.121 0.101 DBMET01321 0.116 0.113 DBMET01323 | ||
| 0.076 | 0.048 | 0.116 | Vanilloid 4 agonist | 0.076 0.05 DBMET01831 0.076 0.05 DBMET01323 0.116 0.008 DBMET01324 | DBMET01324 | |
| 0.04 | 0.012 | 0.041 | Dipeptidyl peptidase I inhibitor | 0.028 0.025 DBMET01830 0.036 0.015 DBMET01831 0.028 0.025 DBMET01321 0.036 0.015 DBMET01323 0.041 0.012 DBMET01324 0.027 0.026 DBMET01322 | DBMET01324 | |
| 0.036 | 0.008 | 0.036 | Thyroid hormone agonist | 0.028 0.015 DBMET01830 0.024 0.021 DBMET01831 0.028 0.015 DBMET01321 0.024 0.021 DBMET01323 | ||
| 0.056 | 0.029 | 0.056 | CC chemokine 5 receptor antagonist | 0.046 0.042 DBMET01830 0.046 0.042 DBMET01321 | ||
| 0.041 | 0.014 | 0.041 | Peptide deformylase inhibitor | 0.027 0.025 DBMET01830 0.027 0.025 DBMET01321 | ||
| 0.069 | 0.043 | 0.324 | Selectin antagonist | 0.066 0.045 DBMET01830 0.067 0.044 DBMET01831 0.066 0.045 DBMET01321 0.067 0.044 DBMET01323 0.059 0.05 DBMET01324 0.324 0.005 DBMET01325 0.065 0.045 DBMET01322 | DBMET01325 | |
| 0.034 | 0.01 | 0.034 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.031 0.013 DBMET01830 0.031 0.013 DBMET01831 0.031 0.013 DBMET01321 0.031 0.013 DBMET01323 0.03 0.015 DBMET01324 0.028 0.017 DBMET01322 | ||
| 0.072 | 0.047 | 0.073 | Peroxisome proliferator-activated receptor gamma agonist | 0.073 0.046 DBMET01831 0.073 0.046 DBMET01323 0.062 0.056 DBMET01324 | DBMET01323 | |
| 0.057 | 0.033 | 0.057 | Matrix metalloproteinase 1 inhibitor | |||
| 0.039 | 0.015 | 0.039 | Dipeptidyl peptidase II inhibitor | |||
| 0.034 | 0.011 | 0.034 | Purinergic P2Y12 antagonist | 0.021 0.018 DBMET01325 0.021 0.018 DBMET01322 | ||
| 0.053 | 0.03 | 0.053 | Antimetabolite | 0.043 0.037 DBMET01830 0.041 0.039 DBMET01831 0.043 0.037 DBMET01321 0.041 0.039 DBMET01323 0.046 0.035 DBMET01324 0.053 0.029 DBMET01325 | ||
| 0.082 | 0.059 | 0.082 | Inducible nitric-oxide synthase inhibitor | |||
| 0.039 | 0.017 | 0.039 | Factor XI inhibitor | 0.035 0.022 DBMET01831 0.035 0.022 DBMET01323 0.033 0.024 DBMET01322 | ||
| 0.089 | 0.066 | 0.089 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.048 | 0.026 | 0.048 | Macrophage elastase inhibitor | 0.038 0.036 DBMET01830 0.038 0.036 DBMET01321 | ||
| 0.054 | 0.032 | 0.054 | Chemokine receptor agonist | 0.045 0.039 DBMET01831 0.045 0.039 DBMET01323 | ||
| 0.032 | 0.01 | 0.032 | Integrin alpha2beta1 antagonist | 0.025 0.021 DBMET01830 0.032 0.01 DBMET01831 0.025 0.021 DBMET01321 0.032 0.01 DBMET01323 0.03 0.012 DBMET01324 0.025 0.021 DBMET01322 | ||
| 0.06 | 0.039 | 0.06 | Plasminogen activator inhibitor | |||
| 0.046 | 0.025 | 0.046 | HIV-1 protease inhibitor | 0.04 0.034 DBMET01830 0.04 0.035 DBMET01831 0.04 0.034 DBMET01321 0.04 0.035 DBMET01323 0.039 0.037 DBMET01324 | ||
| 0.134 | 0.113 | 0.384 | Nitric oxide antagonist | 0.17 0.081 DBMET01831 0.17 0.081 DBMET01323 0.243 0.053 DBMET01324 0.384 0.027 DBMET01325 0.259 0.049 DBMET01322 | DBMET01325 | |
| 0.041 | 0.021 | 0.041 | Glutamate (mGluR8) agonist | 0.038 0.026 DBMET01831 0.038 0.026 DBMET01323 0.038 0.026 DBMET01324 | ||
| 0.053 | 0.033 | 0.055 | Aconitate hydratase inhibitor | 0.055 0.032 DBMET01831 0.055 0.032 DBMET01323 | DBMET01323 | |
| 0.029 | 0.009 | 0.029 | Integrin alphaVbeta3 antagonist | 0.023 0.013 DBMET01830 0.021 0.015 DBMET01831 0.023 0.013 DBMET01321 0.021 0.015 DBMET01323 | ||
| 0.083 | 0.064 | 0.083 | Ornithine decarboxylase inhibitor | 0.076 0.072 DBMET01324 | ||
| 0.127 | 0.108 | 0.135 | Pregnane X receptor agonist | 0.135 0.086 DBMET01831 0.135 0.086 DBMET01323 | DBMET01323 | |
| 0.024 | 0.006 | 0.024 | Angiotensin-converting enzyme 2 inhibitor | 0.02 0.009 DBMET01830 0.022 0.007 DBMET01831 0.02 0.009 DBMET01321 0.022 0.007 DBMET01323 0.02 0.009 DBMET01324 0.018 0.011 DBMET01322 | ||
| 0.045 | 0.027 | 0.045 | Oxytocin agonist | |||
| 0.035 | 0.017 | 0.036 | AMPA 3 receptor antagonist | 0.036 0.016 DBMET01324 | DBMET01324 | |
| 0.143 | 0.125 | 0.207 | Succinate dehydrogenase inhibitor | 0.148 0.117 DBMET01830 0.148 0.117 DBMET01321 0.207 0.043 DBMET01324 | DBMET01324 | |
| 0.045 | 0.027 | 0.045 | Leukocyte elastase inhibitor | |||
| 0.059 | 0.042 | 0.059 | Bombesin 1 receptor agonist | 0.055 0.047 DBMET01830 0.055 0.047 DBMET01321 | ||
| 0.028 | 0.011 | 0.028 | Aminopeptidase P inhibitor | 0.023 0.016 DBMET01830 0.027 0.013 DBMET01831 0.023 0.016 DBMET01321 0.027 0.013 DBMET01323 0.025 0.014 DBMET01324 0.022 0.018 DBMET01322 | ||
| 0.068 | 0.052 | 0.068 | Secretase beta inhibitor | 0.065 0.06 DBMET01831 0.065 0.06 DBMET01323 | ||
| 0.058 | 0.041 | 0.058 | Aminopeptidase microsomal inhibitor | 0.049 0.048 DBMET01831 0.049 0.048 DBMET01323 | ||
| 0.021 | 0.005 | 0.021 | Tryptophan hydroxylase 1 inhibitor | 0.019 0.009 DBMET01830 0.02 0.006 DBMET01831 0.019 0.009 DBMET01321 0.02 0.006 DBMET01323 0.019 0.008 DBMET01324 0.018 0.01 DBMET01322 | ||
| 0.033 | 0.017 | 0.033 | Trypsin II inhibitor | 0.03 0.02 DBMET01830 0.03 0.02 DBMET01321 | ||
| 0.024 | 0.008 | 0.024 | Aminopeptidase A inhibitor | 0.016 0.014 DBMET01830 0.022 0.009 DBMET01831 0.016 0.014 DBMET01321 0.022 0.009 DBMET01323 0.02 0.011 DBMET01324 | ||
| 0.02 | 0.004 | 0.02 | Carboxypeptidase B2 inhibitor | 0.013 0.006 DBMET01830 0.013 0.006 DBMET01321 | ||
| 0.022 | 0.007 | 0.022 | Nicotinic acid receptor 1 antagonist | |||
| 0.061 | 0.045 | 0.061 | Trypsin inhibitor | 0.06 0.048 DBMET01324 | ||
| 0.065 | 0.051 | 0.065 | Sirtuin 1 inhibitor | 0.06 0.059 DBMET01830 0.063 0.053 DBMET01831 0.06 0.059 DBMET01321 0.063 0.053 DBMET01323 0.064 0.053 DBMET01324 | ||
| 0.052 | 0.038 | 0.052 | Elastase inhibitor | |||
| 0.037 | 0.023 | 0.037 | Opioid delta receptor agonist | |||
| 0.02 | 0.006 | 0.02 | Carbonic anhydrase IV stimulant | 0.015 0.01 DBMET01830 0.016 0.009 DBMET01831 0.015 0.01 DBMET01321 0.016 0.009 DBMET01323 0.015 0.01 DBMET01324 | ||
| 0.018 | 0.005 | 0.018 | Integrin alphaVbeta5 antagonist | 0.013 0.005 DBMET01830 0.013 0.005 DBMET01321 | ||
| 0.053 | 0.04 | 0.053 | DNA helicase inhibitor | |||
| 0.073 | 0.06 | 0.077 | Keratolytic | 0.077 0.053 DBMET01830 0.077 0.053 DBMET01321 | DBMET01321 | |
| 0.082 | 0.069 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.025 | 0.012 | 0.025 | Vitronectin receptor antagonist | |||
| 0.042 | 0.029 | 0.042 | Cathepsin F inhibitor | |||
| 0.034 | 0.022 | 0.038 | HCV polyprotein inhibitor | 0.032 0.03 DBMET01830 0.034 0.025 DBMET01831 0.032 0.03 DBMET01321 0.034 0.025 DBMET01323 0.038 0.015 DBMET01324 | DBMET01324 | |
| 0.03 | 0.019 | 0.03 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.027 | 0.016 | 0.037 | Toll-Like receptor 4 agonist | 0.037 0.006 DBMET01325 | DBMET01325 | |
| 0.036 | 0.024 | 0.036 | AMPA receptor agonist | 0.035 0.025 DBMET01324 | ||
| 0.043 | 0.031 | 0.043 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.042 | 0.031 | 0.042 | Carbonic anhydrase IV inhibitor | |||
| 0.073 | 0.063 | 0.073 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.098 | 0.087 | 0.098 | Calcium channel (voltage-sensitive) blocker | |||
| 0.052 | 0.041 | 0.052 | Human rhinovirus A protease inhibitor | |||
| 0.032 | 0.021 | 0.032 | HCV NS5B polymerase inhibitor | |||
| 0.017 | 0.007 | 0.017 | Integrin alphaVbeta6 antagonist | 0.015 0.009 DBMET01830 0.013 0.011 DBMET01831 0.015 0.009 DBMET01321 0.013 0.011 DBMET01323 | ||
| 0.035 | 0.026 | 0.117 | Kainate receptor 2 antagonist | 0.117 0.004 DBMET01324 | DBMET01324 | |
| 0.039 | 0.03 | 0.039 | Cholecystokinin antagonist | |||
| 0.035 | 0.027 | 0.035 | Histone deacetylase 7 inhibitor | |||
| 0.033 | 0.024 | 0.033 | Calpain 1 inhibitor | 0.031 0.029 DBMET01831 0.031 0.029 DBMET01323 0.031 0.029 DBMET01325 | ||
| 0.033 | 0.025 | 0.033 | RNA-directed RNA polymerase inhibitor | |||
| 0.059 | 0.051 | 0.082 | CDC25B inhibitor | 0.082 0.026 DBMET01830 0.082 0.026 DBMET01321 | DBMET01321 | |
| 0.022 | 0.014 | 0.022 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.022 | 0.013 | 0.022 | Integrin beta5 antagonist | |||
| 0.081 | 0.073 | 0.106 | Triose-phosphate isomerase inhibitor | 0.088 0.063 DBMET01830 0.088 0.063 DBMET01321 0.106 0.042 DBMET01325 | DBMET01325 | |
| 0.041 | 0.033 | 0.041 | Histamine H2 receptor agonist | |||
| 0.029 | 0.021 | 0.029 | AMPA 1 receptor antagonist | |||
| 0.152 | 0.145 | 0.152 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.035 | 0.028 | 0.035 | Cholecystokinin A antagonist | |||
| 0.04 | 0.034 | 0.04 | Glutamate (mGluR group III) agonist | |||
| 0.073 | 0.067 | 0.073 | Viral attachment inhibitor | |||
| 0.019 | 0.014 | 0.019 | Integrin beta3 antagonist | |||
| 0.106 | 0.101 | 0.106 | Nav1.2 sodium channel blocker | |||
| 0.053 | 0.049 | 0.058 | Botulinum neurotoxin type A inhibitor | 0.058 0.04 DBMET01324 | DBMET01324 | |
| 0.095 | 0.091 | 0.161 | DNA polymerase I inhibitor | 0.127 0.063 DBMET01831 0.127 0.063 DBMET01323 0.161 0.043 DBMET01325 0.121 0.068 DBMET01322 | DBMET01325 | |
| 0.033 | 0.029 | 0.033 | Growth factor receptor-bound protein 2 antagonist | |||
| 0.019 | 0.015 | 0.019 | Caspase 8 inhibitor | |||
| 0.016 | 0.013 | 0.016 | Thyroid hormone alpha agonist | |||
| 0.041 | 0.038 | 0.041 | Plasmin inhibitor | |||
| 0.035 | 0.032 | 0.035 | Cathepsin L1 inhibitor | |||
| 0.069 | 0.067 | 0.069 | Somatostatin 1 agonist | |||
| 0.033 | 0.031 | 0.036 | Ceramide glucosyltransferase inhibitor | 0.033 0.03 DBMET01830 0.033 0.03 DBMET01321 0.036 0.024 DBMET01325 | DBMET01325 | |
| 0.015 | 0.014 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 DBMET01325 | DBMET01325 | |
| 0.041 | 0.04 | 0.041 | Aminopeptidase N inhibitor | |||
| 0.052 | 0.052 | 0.06 | Carbamoyl phosphate synthetase inhibitor | 0.056 0.047 DBMET01830 0.056 0.048 DBMET01831 0.056 0.047 DBMET01321 0.056 0.048 DBMET01323 0.06 0.043 DBMET01322 | DBMET01322 | |
| 0.017 | 0.017 | 0.026 | 5-Alpha-reductase 2 inhibitor | 0.026 0.01 DBMET01830 0.026 0.01 DBMET01321 | DBMET01321 | |
| 0.015 | 0.016 | 0.02 | Vitamin D receptor agonist | 0.02 0.006 DBMET01830 0.02 0.006 DBMET01321 0.016 0.012 DBMET01325 | DBMET01321 | |
| 0.048 | 0.05 | 0.087 | Heparanase inhibitor | 0.087 0.005 DBMET01325 | DBMET01325 | |
| 0.02 | 0.023 | 0.032 | Vitamin D receptor antagonist | 0.032 0.006 DBMET01830 0.032 0.006 DBMET01321 0.022 0.015 DBMET01325 | DBMET01321 | |
| 0.086 | 0.089 | 0.107 | Ferrochelatase inhibitor | 0.107 0.064 DBMET01324 | DBMET01324 | |
| 0.022 | 0.026 | 0.04 | Vanilloid 2 agonist | 0.04 0.004 DBMET01324 0.035 0.005 DBMET01325 | DBMET01324 | |
| 0.053 | 0.057 | 0.065 | Lipocortins synthesis agonist | 0.056 0.047 DBMET01830 0.056 0.047 DBMET01321 0.065 0.027 DBMET01325 0.056 0.045 DBMET01322 | DBMET01325 | |
| 0.199 | 0.203 | 0.223 | Histamine release inhibitor | 0.223 0.178 DBMET01325 | DBMET01325 | |
| 0.167 | 0.172 | 0.24 | DNA synthesis inhibitor | 0.182 0.151 DBMET01831 0.182 0.151 DBMET01323 0.24 0.074 DBMET01324 0.236 0.077 DBMET01325 0.171 0.166 DBMET01322 | DBMET01324 | |
| 0.042 | 0.048 | 0.047 | Ornithine carbamoyltransferase inhibitor | 0.047 0.043 DBMET01324 | DBMET01324 | |
| 0.09 | 0.099 | 0.093 | Factor V inhibitor | 0.093 0.086 DBMET01831 0.093 0.086 DBMET01323 | DBMET01323 | |
| 0.082 | 0.093 | 0.106 | Anabolic | 0.106 0.054 DBMET01831 0.106 0.054 DBMET01323 0.1 0.062 DBMET01324 0.088 0.081 DBMET01322 | DBMET01323 | |
| 0.025 | 0.036 | 0.034 | Retinoid X receptor agonist | 0.034 0.026 DBMET01324 | DBMET01324 | |
| 0.01 | 0.022 | 0.017 | 5-Alpha-reductase 1 inhibitor | 0.017 0.012 DBMET01830 0.017 0.012 DBMET01321 | DBMET01321 | |
| 0.029 | 0.041 | 0.167 | Kainate receptor antagonist | 0.167 0.004 DBMET01324 | DBMET01324 | |
| 0.148 | 0.161 | 0.291 | Vasodilator | 0.291 0.051 DBMET01324 0.287 0.053 DBMET01325 | DBMET01324 | |
| 0.027 | 0.042 | 0.033 | Melatonin receptor 1A agonist | 0.033 0.025 DBMET01830 0.033 0.025 DBMET01321 | DBMET01321 | |
| 0.022 | 0.038 | 0.027 | Retinoid X gamma receptor antagonist | 0.027 0.019 DBMET01324 | DBMET01324 | |
| 0.01 | 0.028 | 0.051 | Kainate receptor 1 antagonist | 0.051 0.005 DBMET01324 | DBMET01324 | |
| 0.138 | 0.162 | 0.446 | Free radical scavenger | 0.195 0.102 DBMET01324 0.446 0.022 DBMET01325 | DBMET01325 | |
| 0.041 | 0.065 | 0.069 | Cannabinoid CB1 receptor agonist | 0.069 0.036 DBMET01831 0.069 0.036 DBMET01323 | DBMET01323 | |
| 0.022 | 0.048 | 0.039 | Melatonin agonist | 0.035 0.019 DBMET01830 0.035 0.019 DBMET01321 0.03 0.027 DBMET01324 0.039 0.016 DBMET01322 | DBMET01322 | |
| 0.081 | 0.108 | 0.107 | Chelator | 0.107 0.068 DBMET01324 | DBMET01324 | |
| 0.014 | 0.041 | 0.027 | Geranylgeranyltransferase inhibitor | 0.027 0.01 DBMET01324 | DBMET01324 | |
| 0.084 | 0.112 | 0.205 | Alkylator | 0.1 0.088 DBMET01324 0.205 0.025 DBMET01325 | DBMET01325 | |
| 0.04 | 0.069 | 0.062 | Alpha-mannosidase inhibitor | 0.062 0.024 DBMET01325 | DBMET01325 | |
| 0.125 | 0.154 | 0.185 | ATPase inhibitor | 0.14 0.12 DBMET01830 0.14 0.12 DBMET01321 0.185 0.051 DBMET01325 | DBMET01325 | |
| 0.047 | 0.076 | 0.072 | Nitric oxide donor | 0.072 0.03 DBMET01325 | DBMET01325 | |
| 0.046 | 0.076 | 0.07 | Phosphofructokinase-1 inhibitor | 0.07 0.048 DBMET01325 | DBMET01325 | |
| 0.069 | 0.099 | 0.2 | Monophenol monooxygenase inhibitor | 0.2 0.033 DBMET01325 0.103 0.073 DBMET01322 | DBMET01325 | |
| 0.033 | 0.063 | 0.055 | Microtubule stabilization | 0.055 0.022 DBMET01325 | DBMET01325 | |
| 0.035 | 0.065 | 0.09 | Protein 50S ribosomal subunit inhibitor | 0.09 0.016 DBMET01325 | DBMET01325 | |
| 0.123 | 0.161 | 0.132 | Ca2+-transporting ATPase inhibitor | 0.132 0.111 DBMET01325 | DBMET01325 | |
| 0.016 | 0.057 | 0.036 | Leukotriene A4 hydrolase inhibitor | 0.036 0.027 DBMET01831 0.036 0.027 DBMET01323 | DBMET01323 | |
| 0.139 | 0.18 | 0.499 | Antioxidant | 0.225 0.099 DBMET01324 0.499 0.02 DBMET01325 | DBMET01325 | |
| 0.058 | 0.105 | 0.103 | Glycine receptor antagonist | 0.103 0.029 DBMET01831 0.103 0.029 DBMET01323 0.1 0.032 DBMET01324 0.073 0.07 DBMET01325 | DBMET01323 | |
| 0.067 | 0.117 | 0.095 | ATPase (Vacuolar H+) inhibitor | 0.092 0.053 DBMET01830 0.092 0.053 DBMET01321 0.095 0.046 DBMET01325 | DBMET01325 | |
| 0.076 | 0.127 | 0.152 | Toll-Like receptor 4 antagonist | 0.12 0.044 DBMET01830 0.12 0.044 DBMET01321 0.152 0.02 DBMET01325 | DBMET01325 | |
| 0.026 | 0.079 | 0.052 | Mannosidase inhibitor | 0.052 0.023 DBMET01325 | DBMET01325 | |
| 0.017 | 0.074 | 0.064 | Melatonin 2 agonist | 0.035 0.02 DBMET01830 0.035 0.02 DBMET01321 0.034 0.022 DBMET01324 0.064 0.007 DBMET01322 | DBMET01322 | |
| 0.017 | 0.08 | 0.037 | TRPM8 blocker | 0.037 0.028 DBMET01324 | DBMET01324 | |
| 0.038 | 0.103 | 0.099 | Acetyl-CoA transferase 2 inhibitor | 0.052 0.051 DBMET01831 0.052 0.051 DBMET01323 0.099 0.005 DBMET01322 | DBMET01322 | |
| 0.038 | 0.106 | 0.08 | Prostaglandin-E synthase inhibitor | 0.08 0.039 DBMET01831 0.08 0.039 DBMET01323 | DBMET01323 | |
| 0.041 | 0.11 | 0.092 | Na+ K+ transporting ATPase inhibitor | 0.08 0.05 DBMET01324 0.092 0.039 DBMET01325 | DBMET01325 | |
| 0.025 | 0.1 | 0.056 | Neuraminidase (Influenza A) inhibitor | 0.056 0.016 DBMET01325 | DBMET01325 | |
| 0.18 | 0.256 | 0.599 | Antibacterial | 0.225 0.202 DBMET01324 0.599 0.019 DBMET01325 | DBMET01325 | |
| 0.017 | 0.097 | 0.038 | Melatonin 1 agonist | 0.038 0.016 DBMET01322 | DBMET01322 | |
| 0.031 | 0.114 | 0.047 | Cytokine production stimulant | 0.047 0.037 DBMET01325 | DBMET01325 | |
| 0.215 | 0.298 | 0.357 | Caspase 9 stimulant | 0.357 0.14 DBMET01325 | DBMET01325 | |
| 0.059 | 0.152 | 0.12 | Transcription factor NF kappa B stimulant | 0.12 0.025 DBMET01324 0.114 0.028 DBMET01325 | DBMET01324 | |
| 0.03 | 0.127 | 0.164 | Antineoplastic antibiotic | 0.164 0.028 DBMET01325 | DBMET01325 | |
| 0.009 | 0.108 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.006 DBMET01325 | DBMET01325 | |
| 0.105 | 0.208 | 0.238 | Antiamyloidogenic | 0.238 0.077 DBMET01325 | DBMET01325 | |
| 0.023 | 0.129 | 0.041 | Adenosine uptake inhibitor | 0.041 0.011 DBMET01324 | DBMET01324 | |
| 0.023 | 0.138 | 0.056 | Glutamate (mGluR) agonist | 0.056 0.049 DBMET01831 0.056 0.049 DBMET01323 | DBMET01323 | |
| 0.063 | 0.179 | 0.084 | T cell inhibitor | 0.084 0.051 DBMET01830 0.084 0.051 DBMET01321 | DBMET01321 | |
| 0.066 | 0.185 | 0.227 | Lipid peroxidase inhibitor | 0.227 0.032 DBMET01325 | DBMET01325 | |
| 0.058 | 0.182 | 0.207 | Ca(v)3.1 blocker | 0.207 0.004 DBMET01324 | DBMET01324 | |
| 0.01 | 0.137 | 0.034 | Sodium/glucose cotransporter inhibitor | 0.034 0.009 DBMET01325 | DBMET01325 | |
| 0.036 | 0.172 | 0.07 | Adenine nucleotide translocase inhibitor | 0.07 0.015 DBMET01325 | DBMET01325 | |
| 0.095 | 0.238 | 0.141 | 3C-like protease (Human coronavirus) inhibitor | 0.141 0.117 DBMET01324 | DBMET01324 | |
| 0.051 | 0.197 | 0.093 | NADH dehydrogenase inhibitor | 0.093 0.052 DBMET01325 | DBMET01325 | |
| 0.018 | 0.165 | 0.063 | Neuraminidase inhibitor | 0.063 0.04 DBMET01325 | DBMET01325 | |
| 0.085 | 0.235 | 0.155 | Anticonvulsant | 0.155 0.123 DBMET01831 0.155 0.123 DBMET01323 | DBMET01323 | |
| 0.046 | 0.198 | 0.143 | UDP-glucose 4-epimerase inhibitor | 0.143 0.031 DBMET01325 | DBMET01325 | |
| 0.024 | 0.198 | 0.071 | Neuraminidase (influenza) inhibitor | 0.071 0.034 DBMET01325 | DBMET01325 | |
| 0.1 | 0.28 | 0.203 | DNA damaging | 0.203 0.113 DBMET01325 | DBMET01325 | |
| 0.006 | 0.202 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 DBMET01325 | DBMET01325 | |
| 0.017 | 0.227 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 DBMET01325 | DBMET01325 | |
| 0.146 | 0.366 | 0.545 | Apoptosis agonist | 0.423 0.103 DBMET01324 0.545 0.062 DBMET01325 | DBMET01325 | |
| 0.056 | 0.279 | 0.116 | Acetylcholine M1 receptor antagonist | 0.116 0.114 DBMET01324 | DBMET01324 | |
| 0.021 | 0.252 | 0.083 | Glucose-6-phosphate translocase inhibitor | 0.083 0.01 DBMET01325 | DBMET01325 | |
| 0.067 | 0.3 | 0.182 | NOS3 expression enhancer | 0.182 0.049 DBMET01325 | DBMET01325 | |
| 0.069 | 0.336 | 0.154 | Tumour necrosis factor antagonist | 0.154 0.095 DBMET01831 0.154 0.095 DBMET01323 | DBMET01323 | |
| 0.007 | 0.276 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.025 0.015 DBMET01325 | DBMET01325 | |
| 0.062 | 0.356 | 0.337 | Tumour necrosis factor alpha release inhibitor | 0.204 0.105 DBMET01831 0.204 0.105 DBMET01323 0.337 0.041 DBMET01325 | DBMET01325 | |
| 0.009 | 0.327 | 0.053 | Liver X receptor agonist | 0.053 0.021 DBMET01831 0.053 0.021 DBMET01323 0.044 0.029 DBMET01322 | DBMET01323 | |
| 0.025 | 0.42 | 0.1 | Multidrug resistance-associated protein 1 inhibitor | 0.1 0.078 DBMET01325 | DBMET01325 | |
| 0.014 | 0.483 | 0.155 | Topoisomerase I inhibitor | 0.155 0.039 DBMET01325 | DBMET01325 | |
| 0.072 | 0.65 | 0.123 | CC chemokine 6 receptor antagonist | 0.123 0.102 DBMET01325 | DBMET01325 | |
| 0.015 | 0.655 | 0.087 | DNA directed RNA polymerase inhibitor | 0.087 0.074 DBMET01322 | DBMET01322 | |
| 0.021 | 0.697 | 0.138 | MAP3K9 inhibitor | 0.138 0.08 DBMET01831 0.138 0.08 DBMET01323 | DBMET01323 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |